Literature DB >> 11867220

Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cells.

Rita Garuti1, Maria Antonietta Croce, Luana Piccinini, Roberta Tiozzo, Stefano Bertolini, Sebastiano Calandra.   

Abstract

Human sterol 27-hydroxylase catalyses the first step in the alternative pathway of bile acids biosynthesis in hepatocytes. However the gene encoding this enzyme (CYP27 gene) is expressed in every tissue and some evidence suggests that this enzyme plays a role in cholesterol homeostasis. Although modulation of CYP27 expression has been reported, the mechanisms underlying the regulation of this gene in human tissues is still poorly understood. To elucidate the mechanism governing CYP27 expression we cloned a 4.3 kb fragment of the 5' flanking region of the human CYP27 gene and constructed deletion mutants which were transfected into HepG2 cells. Functional assays showed that the -217/-10 nucleotide region from the translation start site (minimal promoter), devoid of TATA and CAAT boxes, contains all the elements for basal transcription. Foot-printing analysis of minimal promoter showed four protected regions (A-D). Regions A, B and D each contain one Sp1 binding site, and region C contains a HNF4 site. Electrophoretic mobility shift assays demonstrated that Sp1, Sp3 and HNF4 transcription factors bind these sites. Mutagenesis of any of these sites resulted in the loss of promoter activity. Co-transfection of the minimal promoter with Sp1 and Sp3 expression vectors transactivated CYP27 gene promoter in Drosophila SL2 cells, which lack endogenous Sp proteins. Transactivation of the minimal promoter was also observed in HeLa cells co-transfected with HNF4 expression vector. Therefore, Sp1, Sp3 and HNF4 co-operate in the expression of the human CYP27 gene in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867220     DOI: 10.1016/s0378-1119(01)00874-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

2.  Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha.

Authors:  Yusuke Inoue; Ai-Ming Yu; Sun Hee Yim; Xiaochao Ma; Kristopher W Krausz; Junko Inoue; Charlie C Xiang; Michael J Brownstein; Gösta Eggertsen; Ingemar Björkhem; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2005-11-01       Impact factor: 5.922

3.  Hormonal regulation of the human sterol 27-hydroxylase gene CYP27A1.

Authors:  Zufan Araya; Wanjin Tang; Kjell Wikvall
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

Review 4.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

5.  Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.

Authors:  Attila Szanto; Szilvia Benko; Istvan Szatmari; Balint L Balint; Ibolya Furtos; Ralph Rühl; Sandor Molnar; Laszlo Csiba; Rita Garuti; Sebastiano Calandra; Hanna Larsson; Ulf Diczfalusy; Laszlo Nagy
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

6.  FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.

Authors:  Dongju Jung; J Philippe York; Li Wang; Chaofeng Yang; Aijun Zhang; Heather L Francis; Paul Webb; Wallace L McKeehan; Gianfranco Alpini; Gene D Lesage; David D Moore; Xuefeng Xia
Journal:  Pflugers Arch       Date:  2013-09-26       Impact factor: 3.657

7.  Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells.

Authors:  Anne-Cathrin Behr; Anna Kwiatkowski; Marcus Ståhlman; Felix Florian Schmidt; Claudia Luckert; Albert Braeuning; Thorsten Buhrke
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.